Ferrandino Michael N, Bagrodia Aditya, Pierre Sean A, Scales Charles D, Rampersaud Edward, Pearle Margaret S, Preminger Glenn M
Comprehensive Kidney Stone Center, Duke University Medical Center, Durham, North Carolina 27710, USA.
J Urol. 2009 Feb;181(2):668-72; discussion 673. doi: 10.1016/j.juro.2008.10.012. Epub 2008 Dec 18.
Diagnostic imaging has a central role in the evaluation and management of urolithiasis. A variety of modalities are available, each with benefits and limitations. Without careful consideration of imaging modalities in quantity and type patients may receive excessive doses of radiation during initial diagnostic and followup evaluations. Therefore, we determined the effective radiation dose associated with an acute stone episode and short-term followup.
A multicenter retrospective study of all patients who presented with an acute stone episode was performed. The analysis included all imaging studies related to stone disease performed within 1 year of the acute event. Using accepted effective radiation dose standards for each of these examinations, the total radiation dose administered was calculated and compared by patient characteristics including stone location, stone number and intervention strategy. The primary outcome assessed was a total radiation dose greater than 50 mSv, the recommended yearly dose limit for occupational exposure by the International Commission on Radiological Protection.
We identified 108 patients who presented to our respective institutions with a primary acute stone episode between 2000 and 2006. The mean age in our cohort was 48.6 years and 50% of the patients were men. Patients underwent an average of 4 radiographic examinations during the 1-year period. Studies performed included a mean of 1.2 plain abdominal films of the kidneys, ureters and bladder (range 0 to 7), 1.7 abdominopelvic computerized tomograms (range 0 to 6) and 1 excretory urogram (range 0 to 3) during the first year of followup. The median total effective radiation dose per patient was 29.7 mSv (IQR 24.2, 45.1). There were 22 (20%) patients who received greater than 50 mSv. Analysis of stone location, number of stones, stone composition, patient age, sex and surgical intervention indicated no statistically significant difference in the probability of receiving a total radiation dose greater than 50 mSv.
A fifth of patients receive potentially significant radiation doses in the short-term followup of an acute stone event. Radiographic imaging remains an integral part of the diagnosis and management of symptomatic urolithiasis. While debate exists regarding the threshold level for radiation induced fatal malignancies, urologists must be cognizant of the radiation exposure to patients, and seek alternative imaging strategies to minimize radiation dose during acute and long-term stone management.
诊断成像在尿路结石的评估和管理中起着核心作用。有多种成像方式可供选择,每种都有其优缺点。如果在初始诊断和随访评估过程中没有仔细考虑成像方式的数量和类型,患者可能会接受过量的辐射剂量。因此,我们确定了与急性结石发作及短期随访相关的有效辐射剂量。
对所有出现急性结石发作的患者进行了一项多中心回顾性研究。分析包括在急性事件发生后1年内进行的所有与结石疾病相关的成像研究。根据这些检查各自公认的有效辐射剂量标准,计算并比较了所给予的总辐射剂量,比较的患者特征包括结石位置、结石数量和干预策略。评估的主要结果是总辐射剂量大于50 mSv,这是国际放射防护委员会建议的职业暴露年度剂量限值。
我们确定了108例在2000年至2006年间因原发性急性结石发作到我们各自机构就诊的患者。我们队列中的患者平均年龄为48.6岁,50%为男性。患者在1年期间平均接受了4次放射学检查。所进行的检查包括在随访的第一年平均1.2次肾脏、输尿管和膀胱的腹部平片(范围为0至7次)、1.7次腹部盆腔计算机断层扫描(范围为0至6次)和1次排泄性尿路造影(范围为0至3次)。每位患者的中位总有效辐射剂量为29.7 mSv(四分位间距24.2, 45.1)。有22例(20%)患者接受的辐射剂量大于50 mSv。对结石位置、结石数量、结石成分、患者年龄、性别和手术干预的分析表明,接受总辐射剂量大于50 mSv的概率没有统计学上的显著差异。
在急性结石事件的短期随访中,五分之一的患者接受了可能具有显著影响的辐射剂量。放射学成像仍然是有症状尿路结石诊断和管理不可或缺的一部分。虽然对于辐射诱发致命性恶性肿瘤的阈值水平存在争议,但泌尿外科医生必须意识到患者所接受的辐射暴露,并寻求替代成像策略,以在急性和长期结石管理期间尽量减少辐射剂量。